These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 17762632

  • 1. New developments in first- and second-line chemotherapy for transitional cell, squamous cell and adenocarcinoma of the bladder.
    De Santis M, Bachner M.
    Curr Opin Urol; 2007 Sep; 17(5):363-8. PubMed ID: 17762632
    [Abstract] [Full Text] [Related]

  • 2. Progress in the chemotherapy of metastatic cancer of the urinary tract.
    Raghavan D.
    Cancer; 2003 Apr 15; 97(8 Suppl):2050-5. PubMed ID: 12673696
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T, Nakamura K, Uchiyama K, Tei Y, Aoki A, Naito K.
    Hinyokika Kiyo; 2006 Feb 15; 52(2):99-105. PubMed ID: 16541762
    [Abstract] [Full Text] [Related]

  • 4. Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy.
    Jessen C, Agerbaek M, Von Der Maase H.
    Acta Oncol; 2009 Feb 15; 48(3):411-7. PubMed ID: 18798018
    [Abstract] [Full Text] [Related]

  • 5. Second-line therapy in bladder cancer.
    Bachner M, De Santis M.
    Curr Opin Urol; 2009 Sep 15; 19(5):533-9. PubMed ID: 19550334
    [Abstract] [Full Text] [Related]

  • 6. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D, Pectasides M, Economopoulos T.
    Cancer Treat Rev; 2006 Oct 15; 32(6):456-70. PubMed ID: 16935429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Means of effective and practical intra-arterial chemotherapy for locally invasive bladder cancer--with special reference to clinical analysis of bladder cancer patients treated by intermittent intra-arterial infusion using an implantable port system].
    Takashima S, Nakamura K, Nakatsuka H, Ogawa R, Kobashi S, Kaminou T, Matsuoka T, Yamada R, Ezaki K, Wada S, Kishimoto T.
    Hinyokika Kiyo; 1999 Feb 15; 45(2):127-31. PubMed ID: 10212787
    [Abstract] [Full Text] [Related]

  • 9. Update on chemotherapy for advanced bladder cancer.
    Rosenberg JE, Carroll PR, Small EJ.
    J Urol; 2005 Jul 15; 174(1):14-20. PubMed ID: 15947569
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of chemotherapy in the management of the patient with T3b bladder cancer.
    Millikan R, Dinney CP.
    Semin Urol Oncol; 1996 May 15; 14(2):81-5. PubMed ID: 8734735
    [Abstract] [Full Text] [Related]

  • 12. [Role of systemic chemotherapy in the treatment of infiltrating cancer of the bladder].
    Gardella S, Estapé J.
    Med Clin (Barc); 1989 Dec 02; 93(18):693-5. PubMed ID: 2607820
    [No Abstract] [Full Text] [Related]

  • 13. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
    McCaffrey JA, Herr HW.
    Surg Oncol Clin N Am; 1997 Oct 02; 6(4):667-81. PubMed ID: 9309087
    [Abstract] [Full Text] [Related]

  • 14. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
    Logothetis CJ, Samuels ML, Selig DE, Wallace S, Johnson DE.
    Cancer Treat Rep; 1985 Jan 02; 69(1):33-8. PubMed ID: 2981619
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 02; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 16. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
    Azuma H, Kotake Y, Yamamoto K, Sakamoto T, Kiyama S, Ubai T, Inamoto T, Takahara K, Matsuki M, Segawa N, Shibahara N, Katsuoka Y.
    Am J Clin Oncol; 2008 Feb 02; 31(1):11-21. PubMed ID: 18376222
    [Abstract] [Full Text] [Related]

  • 17. The evolving role of chemotherapy in advanced urothelial cancer.
    Calabrò F, Sternberg CN.
    Curr Opin Support Palliat Care; 2007 Oct 02; 1(3):180-6. PubMed ID: 18685360
    [Abstract] [Full Text] [Related]

  • 18. Management of advanced bladder cancer in patients with impaired renal function.
    Bournakis E, Dimopoulos MA, Bamias A.
    Expert Rev Anticancer Ther; 2011 Jun 02; 11(6):931-9. PubMed ID: 21707290
    [Abstract] [Full Text] [Related]

  • 19. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF, Nelli F.
    Expert Rev Anticancer Ther; 2006 Jan 02; 6(1):83-92. PubMed ID: 16375647
    [Abstract] [Full Text] [Related]

  • 20. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr 02; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.